JP2014508610A5 - - Google Patents

Download PDF

Info

Publication number
JP2014508610A5
JP2014508610A5 JP2013557128A JP2013557128A JP2014508610A5 JP 2014508610 A5 JP2014508610 A5 JP 2014508610A5 JP 2013557128 A JP2013557128 A JP 2013557128A JP 2013557128 A JP2013557128 A JP 2013557128A JP 2014508610 A5 JP2014508610 A5 JP 2014508610A5
Authority
JP
Japan
Prior art keywords
molecular weight
hyperbranched polymer
cationic
core portion
polymer molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013557128A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014508610A (ja
JP6251039B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/054179 external-priority patent/WO2012123384A1/en
Publication of JP2014508610A publication Critical patent/JP2014508610A/ja
Publication of JP2014508610A5 publication Critical patent/JP2014508610A5/ja
Application granted granted Critical
Publication of JP6251039B2 publication Critical patent/JP6251039B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013557128A 2011-03-11 2012-03-09 固定化された生物学的成分の改良 Active JP6251039B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161451732P 2011-03-11 2011-03-11
US61/451,732 2011-03-11
PCT/EP2012/054179 WO2012123384A1 (en) 2011-03-11 2012-03-09 Improvements to immobilised biological entities

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017225620A Division JP6643298B2 (ja) 2011-03-11 2017-11-24 固定化された生物学的成分の改良

Publications (3)

Publication Number Publication Date
JP2014508610A JP2014508610A (ja) 2014-04-10
JP2014508610A5 true JP2014508610A5 (https=) 2015-04-30
JP6251039B2 JP6251039B2 (ja) 2017-12-20

Family

ID=45814511

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2013557128A Active JP6251039B2 (ja) 2011-03-11 2012-03-09 固定化された生物学的成分の改良
JP2017225620A Active JP6643298B2 (ja) 2011-03-11 2017-11-24 固定化された生物学的成分の改良
JP2019161946A Pending JP2019202226A (ja) 2011-03-11 2019-09-05 固定化された生物学的成分の改良
JP2020195102A Active JP7222963B2 (ja) 2011-03-11 2020-11-25 固定化された生物学的成分の改良
JP2022196345A Pending JP2023017012A (ja) 2011-03-11 2022-12-08 固定化された生物学的成分の改良

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2017225620A Active JP6643298B2 (ja) 2011-03-11 2017-11-24 固定化された生物学的成分の改良
JP2019161946A Pending JP2019202226A (ja) 2011-03-11 2019-09-05 固定化された生物学的成分の改良
JP2020195102A Active JP7222963B2 (ja) 2011-03-11 2020-11-25 固定化された生物学的成分の改良
JP2022196345A Pending JP2023017012A (ja) 2011-03-11 2022-12-08 固定化された生物学的成分の改良

Country Status (10)

Country Link
US (5) US9101696B2 (https=)
EP (2) EP2683420B1 (https=)
JP (5) JP6251039B2 (https=)
KR (1) KR101933237B1 (https=)
CN (2) CN105664252B (https=)
BR (1) BR112013023241B1 (https=)
CA (1) CA2828797C (https=)
ES (2) ES2955183T3 (https=)
RU (1) RU2625756C2 (https=)
WO (1) WO2012123384A1 (https=)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2955183T3 (es) 2011-03-11 2023-11-29 Gore & Ass Mejoras para las entidades biológicas inmovilizadas
US9283072B2 (en) 2012-07-25 2016-03-15 W. L. Gore & Associates, Inc. Everting transcatheter valve and methods
US10376360B2 (en) 2012-07-27 2019-08-13 W. L. Gore & Associates, Inc. Multi-frame prosthetic valve apparatus and methods
US9101469B2 (en) 2012-12-19 2015-08-11 W. L. Gore & Associates, Inc. Prosthetic heart valve with leaflet shelving
US10321986B2 (en) 2012-12-19 2019-06-18 W. L. Gore & Associates, Inc. Multi-frame prosthetic heart valve
US9737398B2 (en) 2012-12-19 2017-08-22 W. L. Gore & Associates, Inc. Prosthetic valves, frames and leaflets and methods thereof
US9968443B2 (en) 2012-12-19 2018-05-15 W. L. Gore & Associates, Inc. Vertical coaptation zone in a planar portion of prosthetic heart valve leaflet
US9144492B2 (en) 2012-12-19 2015-09-29 W. L. Gore & Associates, Inc. Truncated leaflet for prosthetic heart valves, preformed valve
AU2014211351B2 (en) 2013-02-04 2017-04-13 W. L. Gore & Associates, Inc. Coating for substrate
DE102013016750A1 (de) * 2013-10-02 2015-04-02 Friedrich-Schiller-Universität Jena Neue Poly(ethylenimin) basierte Copolymere zur Anbindung und Freisetzung von genetischem Material, insbesondere von DNA/RNA, sowie Verfahren zu deren Herstellung und Verwendung
EP3078389B1 (en) * 2013-11-28 2020-04-01 Toray Industries, Inc. Antithrombotic material
CN103832021B (zh) * 2014-01-09 2016-03-02 西南交通大学 一种钛基底上制备有机分子杂化TiO2纳米复合薄膜的方法
US11839698B2 (en) * 2014-03-13 2023-12-12 W. L. Gore & Associates, Inc. Drug composition and coating
GR20140100263A (el) * 2014-05-02 2016-02-01 Εκεφε Δημοκριτος Καινοτομα υλικα με βαση τον ανθρακα τροποποιημενα με δενδριτικα πολυμερη, που εμφανιζουν αντιβακτηριακη δραση και η επιδραση τους στη φωτοσυνδετικη λειτουργια
TWI660722B (zh) * 2014-05-09 2019-06-01 日商東麗股份有限公司 血管內治療輔助器具
WO2015188716A1 (zh) * 2014-06-09 2015-12-17 上海微创医疗器械(集团)有限公司 一种抗凝血涂层及其涂覆方法
CA2979779C (en) * 2015-03-31 2023-06-20 Toray Industries, Inc. Antithrombotic metallic material
EP3095509A1 (en) * 2015-05-18 2016-11-23 Defymed Membranes functionalized with heparin for bioartificial organs
WO2016190407A1 (ja) * 2015-05-27 2016-12-01 東レ株式会社 抗血栓性材料
CN106730051B (zh) * 2016-12-27 2020-05-01 生纳科技(上海)有限公司 抗凝血高分子生物材料及其制备方法和应用
EP3577179B1 (en) * 2017-01-31 2024-06-19 The Regents of The University of California Multi-arm block-copolymers for multifunctional self-assembled systems
EP3681440A1 (en) 2017-09-12 2020-07-22 W. L. Gore & Associates, Inc. Leaflet frame attachment for prosthetic valves
JP6875601B2 (ja) 2017-09-27 2021-05-26 ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティドW.L. Gore & Associates, Incorporated リーフレットが機械的にカップリングされた人工弁
EP3687451B1 (en) 2017-09-27 2023-12-13 Edwards Lifesciences Corporation Prosthetic valve with expandable frame
CA3078699C (en) 2017-10-13 2023-10-10 W.L. Gore & Associates, Inc. Telescoping prosthetic valve and delivery system
US11439502B2 (en) 2017-10-31 2022-09-13 W. L. Gore & Associates, Inc. Medical valve and leaflet promoting tissue ingrowth
JP7072062B2 (ja) 2017-10-31 2022-05-19 ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティド 経カテーテル留置システム及び関連する方法
KR102772724B1 (ko) 2018-03-07 2025-02-24 포슝스베르분드 베를린 에.베. 알켄 또는 알킨-포스포노티올레이트 및 -포스포네이트로의 화학선택적 티올-접합
US20190275212A1 (en) 2018-03-09 2019-09-12 Carmeda Ab Processes for immobilising biological entities
WO2019170859A2 (en) 2018-03-09 2019-09-12 Carmeda Ab Improvements to immobilising biological entities
EP3781222A4 (en) * 2018-04-20 2022-01-26 Ension, Inc. MANIPULATED BIOACTIVE HEPARIN MATRIX FOR CLINICAL APPLICATION OF A BLOOD CONTACT SURFACE AND METHODS FOR ITS MANUFACTURE
CA3110044A1 (en) 2018-10-03 2020-04-09 Carmeda Ab Immobilised biological entities
US11497601B2 (en) 2019-03-01 2022-11-15 W. L. Gore & Associates, Inc. Telescoping prosthetic valve with retention element
CN110028692B (zh) * 2019-03-14 2020-11-03 江苏赛腾医疗科技有限公司 一种基于离子键-共价键协同表面肝素化抗凝血医用装置的制备方法
EP3952790A1 (en) 2019-04-12 2022-02-16 W.L. Gore & Associates, Inc. Valve with multi-part frame and associated resilient bridging features
CN110464882A (zh) * 2019-07-29 2019-11-19 东华大学 一种亲水抗菌可降解的输尿管支架管及其制备方法
US20220273426A1 (en) 2019-08-01 2022-09-01 W. L. Gore & Associates, Inc. Transcatheter prosthetic valve with multi-part frame subcomponent transverse deformation resistance
CN114340726A (zh) 2019-08-07 2022-04-12 W.L.戈尔及同仁股份有限公司 用于光可激活的治疗介质的囊体递送装置
CN111544646A (zh) * 2020-03-30 2020-08-18 东华大学 表面接枝肝素涂层的小口径人工血管及其制备方法
AU2022261713B2 (en) 2021-04-19 2025-11-27 W. L. Gore & Associates, Inc. Electrochemical analyte biosensors, associated compositions of matter, and methods for making and using same
EP4333922B8 (en) * 2021-05-04 2025-12-31 Institut national de la santé et de la recherche médicale (INSERM) NEW DEVICES TO BE USED FOR THE TREATMENT OF CEREBRAL ANEURYSMS
CN117500484A (zh) 2021-06-08 2024-02-02 W.L.戈尔及同仁股份有限公司 治疗介质递送装置和用于其靶向递送的方法
CN114392738B (zh) * 2022-01-25 2023-01-10 同济大学 共价杂配体、炔基化超支化聚乙撑亚胺矿化法调制金纳米簇和方法、应用
CN115381569A (zh) * 2022-07-21 2022-11-25 南方科技大学 Peek种植体表面改进方法和设备
US20250387532A1 (en) * 2024-06-19 2025-12-25 W. L. Gore & Associates, Inc. Implantable absorbable tissue adhesives on biomaterials for long-term adhesion to biological tissues

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA962021A (en) 1970-05-21 1975-02-04 Robert W. Gore Porous products and process therefor
JPS6041948B2 (ja) 1977-12-15 1985-09-19 ユニチカ株式会社 固体表面に抗血栓性を付与する方法
US4415490A (en) 1979-07-24 1983-11-15 Nippon Zeon Co., Ltd. Non-thrombogenic material
US4329383A (en) 1979-07-24 1982-05-11 Nippon Zeon Co., Ltd. Non-thrombogenic material comprising substrate which has been reacted with heparin
US4326532A (en) 1980-10-06 1982-04-27 Minnesota Mining And Manufacturing Company Antithrombogenic articles
US4678671A (en) 1981-12-15 1987-07-07 Cordis Europa N.V. Conjugates of anticoagulant and protein
US4526714A (en) 1982-12-13 1985-07-02 Cordis Europa N.V. Conjugates of anticoagulant and protein
SE456347B (sv) 1982-02-09 1988-09-26 Ird Biomaterial Ab Ytmodifierat fast substrat samt forfarande for framstellning derav
SE8200751L (sv) 1982-02-09 1983-08-10 Olle Larm Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter
US4600652A (en) 1985-04-01 1986-07-15 Warner-Lambert Company Permanently bonded antithrombogenic polyurethane surface
IT1213023B (it) 1986-01-16 1989-12-07 Rolando Barbucci Materiale capace di adsorbire stabilmente elevate quantita' di eparina, e suo procedimento di preparazione.
SE452551B (sv) 1986-05-27 1987-12-07 Camurus Ab Artikel belagd med heparinbaserat material samt forfarande for dess framstellning
US4745180A (en) 1986-06-27 1988-05-17 Cetus Corporation Solubilization of proteins for pharmaceutical compositions using heparin fragments
US5527524A (en) * 1986-08-18 1996-06-18 The Dow Chemical Company Dense star polymer conjugates
US5308617A (en) 1988-08-10 1994-05-03 Halzyme Ltd. Protein heparin conjugates
US5130143A (en) 1988-11-04 1992-07-14 The Research Foundation Of State University Of New York Use of a low affinity-heparin fraction in conjunction with t-pa for thrombolytic therapy
US5510418A (en) 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
US5032666A (en) 1989-06-19 1991-07-16 Becton, Dickinson And Company Amine rich fluorinated polyurethaneureas and their use in a method to immobilize an antithrombogenic agent on a device surface
US5049403A (en) 1989-10-12 1991-09-17 Horsk Hydro A.S. Process for the preparation of surface modified solid substrates
US5213898A (en) 1989-10-12 1993-05-25 Norsk Hydro A.S. Process for the preparation of surface modified solid substrates
WO1993005825A1 (en) 1991-09-20 1993-04-01 Baxter International Inc. Processes for reducing the thrombogenicity of biomaterials
SE470006B (sv) 1991-09-26 1993-10-25 Corline Systems Ab Nytt konjugat, dess framställning och användning samt substrat preparerat med konjugatet
IT1254898B (it) 1992-04-21 1995-10-11 Gianfranco Palumbo Idrogeli di tipo polietereammidoamminico come materiali eparinizzabili
US5532311A (en) 1995-02-01 1996-07-02 Minnesota Mining And Manufacturing Company Process for modifying surfaces
US6099562A (en) 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
US6120536A (en) 1995-04-19 2000-09-19 Schneider (Usa) Inc. Medical devices with long term non-thrombogenic coatings
US5583213A (en) 1995-05-12 1996-12-10 Minnesota Mining And Manufacturing Company Process to activate sulfated polysaccharides
US5767108A (en) 1995-08-22 1998-06-16 Medtronic, Inc. Method for making improved heparinized biomaterials
US5679659A (en) 1995-08-22 1997-10-21 Medtronic, Inc. Method for making heparinized biomaterials
US7045585B2 (en) 1995-11-30 2006-05-16 Hamilton Civic Hospital Research Development Inc. Methods of coating a device using anti-thrombin heparin
NZ325248A (en) 1995-12-23 1999-09-29 Pfizer Res & Dev Quinoline and quinazoline compounds useful in therapy
US5922690A (en) 1996-04-25 1999-07-13 Van Gorp; Cornelius L. Dermatan disulfate, an inhibitor of thrombin generation and activation
GB9608882D0 (en) 1996-04-30 1996-07-03 Luthra Ajay K Non-thrombogenic and anti-thrombogenic polymers
US7034061B1 (en) * 1996-04-30 2006-04-25 Ajay Kumar Luthra Non-thrombogenic and anti-thrombogenic polymers
US5876433A (en) 1996-05-29 1999-03-02 Ethicon, Inc. Stent and method of varying amounts of heparin coated thereon to control treatment
US5916585A (en) 1996-06-03 1999-06-29 Gore Enterprise Holdings, Inc. Materials and method for the immobilization of bioactive species onto biodegradable polymers
US5914182A (en) 1996-06-03 1999-06-22 Gore Hybrid Technologies, Inc. Materials and methods for the immobilization of bioactive species onto polymeric substrates
US5728751A (en) 1996-11-25 1998-03-17 Meadox Medicals, Inc. Bonding bio-active materials to substrate surfaces
JPH114883A (ja) 1997-06-18 1999-01-12 Toray Ind Inc 抗血栓性医療材料
CA2305726A1 (en) 1997-10-07 1999-04-15 Regents Of The University Of California Treating occlusive peripheral vascular disease and coronary disease with combinations of heparin and an adenoside a2 agonist, or with adenosine
FI974321A0 (fi) 1997-11-25 1997-11-25 Jenny Ja Antti Wihurin Rahasto Multipel heparinglykosaminoglykan och en proteoglykan innehaollande dessa
US6361559B1 (en) 1998-06-10 2002-03-26 Converge Medical, Inc. Thermal securing anastomosis systems
GB9814420D0 (en) 1998-07-03 1998-09-02 Cancer Res Campaign Tech Sequence analysis of saccharide material
US6248127B1 (en) 1998-08-21 2001-06-19 Medtronic Ave, Inc. Thromboresistant coated medical device
NO984143L (no) 1998-09-09 2000-03-10 Norsk Hydro As Ny prosess for å fremstille overflatemodifiserende stoffer
MXPA01010692A (es) 1999-04-22 2004-09-06 Univ Zuerich Matrices de proteina modificadas para ingenieria de tejidos o liberacion controlada.
JP2003512490A (ja) 1999-10-19 2003-04-02 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガナイゼイション 機能性高分子表面の調製方法
US6936066B2 (en) 1999-11-19 2005-08-30 Advanced Bio Prosthetic Surfaces, Ltd. Complaint implantable medical devices and methods of making same
US7736687B2 (en) 2006-01-31 2010-06-15 Advance Bio Prosthetic Surfaces, Ltd. Methods of making medical devices
SE515295C2 (sv) 1999-11-23 2001-07-09 Medicarb Ab Förfarande för framställning av konjugat av en biologiskt aktiv polysackarid och ett fast substrat, samt sådana konjugat
GB9928956D0 (en) * 1999-12-07 2000-02-02 Malik Navid Internally supported biomimetic coating systems
US6518244B2 (en) 2000-03-09 2003-02-11 Intimax Corporation Combinations of heparin cofactor II agonist and platelet IIb/IIIa antagonist, and uses thereof
US7875283B2 (en) 2000-04-13 2011-01-25 Advanced Cardiovascular Systems, Inc. Biodegradable polymers for use with implantable medical devices
EP1278559B1 (en) 2000-04-28 2008-03-26 Baylor College Of Medicine Decellularised vascular prostheses
ATE307625T1 (de) 2000-05-12 2005-11-15 Cordis Corp Wirkstoffabgabesysteme zur behandlung von gefässerkrankungen
US6509104B2 (en) 2000-12-05 2003-01-21 Michigan Biotechnology Institute Antithrombogenic polymer coating
US20050059068A1 (en) 2001-05-23 2005-03-17 Stratagene California Compositions and methods using dendrimer-treated microassays
US6787179B2 (en) 2001-06-29 2004-09-07 Ethicon, Inc. Sterilization of bioactive coatings
AR038269A1 (es) 2002-01-09 2005-01-12 Novartis Ag Articulos polimericos que tienen un recubrimiento lubrico, y metodo para fabricarlos
US20030135195A1 (en) 2002-01-16 2003-07-17 Oscar Jimenez Highly lubricious hydrophilic coating utilizing dendrimers
JP2005044408A (ja) 2003-07-24 2005-02-17 Pioneer Electronic Corp 光集積装置および光ピックアップ装置
WO2005018552A2 (en) 2003-08-12 2005-03-03 University Of Utah Research Foundation Heparin binding proteins: sensors for heparin detection
JP2007532187A (ja) 2004-04-06 2007-11-15 サーモディクス,インコーポレイティド 生物活性物質のためのコーティング組成物
GB0422877D0 (en) 2004-10-14 2004-11-17 Univ Glasgow Bioactive polymers
EP1879552B1 (en) 2005-03-14 2016-02-17 Biotegra, Inc. Drug delivery compositions comprising a polyelectrolyte complex within a polymeric matrix
US7767420B2 (en) 2005-11-03 2010-08-03 Momenta Pharmaceuticals, Inc. Heparan sulfate glycosaminoglycan lyase and uses thereof
EP1832289A3 (en) 2006-03-08 2007-12-12 Sahajanand Medical Technologies PVT. ltd Compositions and coatings for implantable medical devices
US8986713B2 (en) 2006-05-12 2015-03-24 W. L. Gore & Associates, Inc. Medical device capable of being compacted and expanded having anti-thrombin III binding activity
EP2023967B1 (en) 2006-05-12 2017-03-22 W. L. Gore & Associates, Inc. Immobilized biologically active entities having a high degree of biological activity following mecanical manipulation or sterilization
US20080279909A1 (en) 2006-05-12 2008-11-13 Cleek Robert L Immobilized Biologically Active Entities Having A High Degree of Biological Activity Following Sterilization
US9114194B2 (en) 2006-05-12 2015-08-25 W. L. Gore & Associates, Inc. Immobilized biologically active entities having high biological activity following mechanical manipulation
WO2008063157A2 (en) 2006-10-25 2008-05-29 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services A nanoparticle-based anticoagulant
DE102008021894A1 (de) 2008-05-02 2009-11-05 Biotronik Vi Patent Ag Implantat umfassend eine Oberfläche mit verringerter Thrombogenität
GB0816783D0 (en) 2008-09-15 2008-10-22 Carmeda Ab Immobilised biological entities
GB201004101D0 (en) 2010-03-12 2010-04-28 Carmeda Ab Immobilised biological entities
ES2955183T3 (es) * 2011-03-11 2023-11-29 Gore & Ass Mejoras para las entidades biológicas inmovilizadas
GB2508574B (en) 2012-06-24 2014-12-17 Fasmatech Science And Technology Sa Improvements in and relating to the control of ions

Similar Documents

Publication Publication Date Title
JP2014508610A5 (https=)
Liang et al. Ca2+ enhanced nacre-inspired montmorillonite–alginate film with superior mechanical, transparent, fire retardancy, and shape memory properties
Yang et al. Well-dispersed chitosan/graphene oxide nanocomposites
Wang et al. Zeolitic imidazolate framework/graphene oxide hybrid nanosheets functionalized thin film nanocomposite membrane for enhanced antimicrobial performance
RU2013145487A (ru) Усовершенствованные иммобилизованные биологические объекты
Jose et al. Effect of bentonite clay on the mechanical, thermal, and pervaporation performance of the poly (vinyl alcohol) nanocomposite membranes
Carlmark et al. Atom transfer radical polymerization from cellulose fibers at ambient temperature
JP2012502678A5 (https=)
Wang et al. O-(Carboxymethyl)-chitosan nanofiltration membrane surface functionalized with graphene oxide nanosheets for enhanced desalting properties
Yin et al. Hemocompatible polyethersulfone/polyurethane composite membrane for high‐performance antifouling and antithrombotic dialyzer
Rajesh et al. Development of graphene oxide framework membranes via the “from” and “to” cross-linking approach for ion-selective separations
JP2014534467A5 (https=)
Eskandarloo et al. Highly efficient recovery of heparin using a green and low-cost quaternary ammonium functionalized halloysite nanotube
US20150344666A1 (en) Laminates Comprising Oligomer-Grafted Nanofillers and Advanced Composite Materials
CN101462388B (zh) 以环状分子与聚合物的包结物增强的复合膜及其制备方法
JP2010215657A5 (https=)
JP2013521838A5 (https=)
Ren et al. Stereocomplex crystallite-based eco-friendly nanofiber membranes for removal of Cr (VI) and antibacterial effects
Liu et al. Syntheses of novel chitosan derivative with excellent solubility, anticoagulation, and antibacterial property by chemical modification
Lee et al. High strength poly (vinyl alcohol)/poly (acrylic acid) cross-linked nanofibrous hybrid composites incorporating nanohybrid POSS
Xiang et al. Elastomeric polymer multilayer thin film with sustainable gas barrier at high strain
JP2011511874A5 (https=)
JP2013023516A5 (https=)
Wang et al. Mussel-inspired codepositing interconnected polypyrrole nanohybrids onto cellulose nanofiber networks for fabricating flexible conductive biobased composites
WO2008136773A8 (en) Functionalization of nanoparticles by glucosamine derivatives